In this issue:
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma
Real-world outcomes of immune checkpoint inhibitors in people living with HIV and skin cancer
Clinician–patient discordance in cutaneous chronic GVHD
Acne incidence and severity in transgender individuals
Methotrexate versus mycophenolate mofetil in juvenile localized scleroderma
GHiSA screening questionnaire for hidradenitis suppurativa
Recurrence and relapse in nonsegmental vitiligo
Cost comparison of radiotherapy and imiquimod for lentigo maligna
Primary melanoma location and mortality
Baricitinib 3-year data in severe alopecia areata
Please login below to download this issue (PDF)